User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

  1. National Hemophilia Foundation, Medical and Scientific Advisory Council (MASAC) Recommendations Concerning Prophylaxis (1994)
  2. Berntorp, Astermark, Jurgutis, Lethagen, Petersson, The Malmo-Klaipeda WFH twinning programme: a comparative description of the Haemophilia cohorts, 10.1046/j.1365-2516.1998.00169.x
  3. , Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders, 10.1046/j.1365-2516.2003.00711.x
  4. ?Delivery of treatment for haemophilia?
  5. Manco-Johnson M, Haemophilia, 12 (2006)
  6. Roosendaal G, J Rheumatol, 27, 1740 (2000)
  7. Santagostino, Mannucci, Bianchi Bonomi, Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy, 10.1046/j.1365-2516.2000.00361.x
  8. Dijk K., Fischer K., Bom J. G., Scheibel E., Ingerslev J., Berg H. M., Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands, 10.1111/j.1365-2141.2005.05546.x
  9. Fischer K., Van Der Bom J. G., Prejs R., Mauser-Bunschoten E. P., Roosendaal G., Grobbee D. E., Van Den Berg H. M., Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome, 10.1046/j.1365-2516.2001.00560.x
Bibliographic reference Richards, Michael ; Altisent, Carmen ; Angelika, Angelika ; Chambost, Hervé ; Dolan, Gerry ; et. al. Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. In: Haemophilia, Vol. 13, no. 5, p. 473-479 (2007)
Permanent URL http://hdl.handle.net/2078.1/37370